Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
INTRACELLULAR SIGNAL TRANSDUCTION |
71 |
1572 |
6.789e-20 |
3.159e-16 |
2 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
76 |
1848 |
5.503e-19 |
8.534e-16 |
3 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
79 |
1977 |
4.851e-19 |
8.534e-16 |
4 |
RESPONSE TO ENDOGENOUS STIMULUS |
64 |
1450 |
2.281e-17 |
2.122e-14 |
5 |
PROTEIN PHOSPHORYLATION |
51 |
944 |
2.216e-17 |
2.122e-14 |
6 |
RESPONSE TO HORMONE |
49 |
893 |
5.581e-17 |
3.694e-14 |
7 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
52 |
1008 |
7.145e-17 |
3.694e-14 |
8 |
PHOSPHORYLATION |
58 |
1228 |
4.798e-17 |
3.694e-14 |
9 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
71 |
1784 |
6.551e-17 |
3.694e-14 |
10 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
71 |
1805 |
1.215e-16 |
5.655e-14 |
11 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
38 |
552 |
1.921e-16 |
8.127e-14 |
12 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
59 |
1381 |
2.345e-15 |
9.091e-13 |
13 |
POSITIVE REGULATION OF GENE EXPRESSION |
67 |
1733 |
2.659e-15 |
9.517e-13 |
14 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
64 |
1618 |
4.545e-15 |
1.511e-12 |
15 |
REGULATION OF CELL DEATH |
60 |
1472 |
1.068e-14 |
3.313e-12 |
16 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
43 |
799 |
1.153e-14 |
3.354e-12 |
17 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
65 |
1710 |
1.737e-14 |
4.755e-12 |
18 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
47 |
1004 |
1.018e-13 |
2.632e-11 |
19 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
57 |
1492 |
8.567e-13 |
2.098e-10 |
20 |
REGULATION OF CELL PROLIFERATION |
57 |
1496 |
9.561e-13 |
2.224e-10 |
21 |
RESPONSE TO NITROGEN COMPOUND |
41 |
859 |
2.558e-12 |
5.668e-10 |
22 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
53 |
1360 |
3.015e-12 |
6.378e-10 |
23 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
48 |
1192 |
1.237e-11 |
2.502e-09 |
24 |
HOMEOSTATIC PROCESS |
51 |
1337 |
1.844e-11 |
3.574e-09 |
25 |
REGULATION OF RESPONSE TO STRESS |
53 |
1468 |
5.352e-11 |
9.962e-09 |
26 |
RESPONSE TO PEPTIDE |
26 |
404 |
6.49e-11 |
1.122e-08 |
27 |
NEGATIVE REGULATION OF CELL DEATH |
39 |
872 |
6.513e-11 |
1.122e-08 |
28 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
41 |
957 |
7.449e-11 |
1.204e-08 |
29 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
29 |
505 |
7.506e-11 |
1.204e-08 |
30 |
REGULATION OF KINASE ACTIVITY |
36 |
776 |
1.406e-10 |
2.181e-08 |
31 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
35 |
740 |
1.548e-10 |
2.323e-08 |
32 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
56 |
1656 |
1.669e-10 |
2.426e-08 |
33 |
REGULATION OF TRANSFERASE ACTIVITY |
40 |
946 |
1.932e-10 |
2.724e-08 |
34 |
CELLULAR RESPONSE TO PEPTIDE |
21 |
274 |
2.033e-10 |
2.783e-08 |
35 |
REGULATION OF LIPID METABOLIC PROCESS |
21 |
282 |
3.454e-10 |
4.592e-08 |
36 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
33 |
689 |
3.943e-10 |
5.096e-08 |
37 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
52 |
1517 |
5.385e-10 |
6.772e-08 |
38 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
35 |
788 |
8.264e-10 |
9.859e-08 |
39 |
CIRCULATORY SYSTEM DEVELOPMENT |
35 |
788 |
8.264e-10 |
9.859e-08 |
40 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
60 |
1929 |
8.642e-10 |
1.005e-07 |
41 |
NEGATIVE REGULATION OF GENE EXPRESSION |
51 |
1493 |
9.21e-10 |
1.045e-07 |
42 |
PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS |
10 |
49 |
9.796e-10 |
1.085e-07 |
43 |
TISSUE DEVELOPMENT |
51 |
1518 |
1.626e-09 |
1.76e-07 |
44 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
54 |
1672 |
1.986e-09 |
2.1e-07 |
45 |
REGULATION OF IMMUNE SYSTEM PROCESS |
48 |
1403 |
3.007e-09 |
3.11e-07 |
46 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
42 |
1135 |
3.596e-09 |
3.638e-07 |
47 |
CELLULAR RESPONSE TO LIPID |
25 |
457 |
4.394e-09 |
4.35e-07 |
48 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
30 |
643 |
4.816e-09 |
4.669e-07 |
49 |
RESPONSE TO LIPID |
36 |
888 |
5.24e-09 |
4.976e-07 |
50 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
26 |
498 |
5.597e-09 |
5.208e-07 |
51 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
33 |
767 |
5.758e-09 |
5.253e-07 |
52 |
REGULATION OF CATABOLIC PROCESS |
32 |
731 |
6.623e-09 |
5.926e-07 |
53 |
CELLULAR COMPONENT MORPHOGENESIS |
36 |
900 |
7.429e-09 |
6.522e-07 |
54 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
39 |
1036 |
8.785e-09 |
7.432e-07 |
55 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
39 |
1036 |
8.785e-09 |
7.432e-07 |
56 |
LIPID PHOSPHORYLATION |
12 |
99 |
1.059e-08 |
8.797e-07 |
57 |
INOSITOL LIPID MEDIATED SIGNALING |
13 |
124 |
1.529e-08 |
1.249e-06 |
58 |
PEPTIDYL SERINE MODIFICATION |
14 |
148 |
1.61e-08 |
1.291e-06 |
59 |
LOCOMOTION |
40 |
1114 |
2.05e-08 |
1.616e-06 |
60 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
54 |
1791 |
2.144e-08 |
1.635e-06 |
61 |
REGULATION OF CELL DIFFERENTIATION |
48 |
1492 |
2.116e-08 |
1.635e-06 |
62 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
37 |
983 |
2.22e-08 |
1.666e-06 |
63 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
24 |
465 |
2.768e-08 |
2.044e-06 |
64 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
24 |
470 |
3.389e-08 |
2.464e-06 |
65 |
IMMUNE SYSTEM PROCESS |
57 |
1984 |
4.314e-08 |
3.088e-06 |
66 |
PROTEIN DEPHOSPHORYLATION |
15 |
190 |
5.658e-08 |
3.989e-06 |
67 |
REGULATION OF CELL ACTIVATION |
24 |
484 |
5.884e-08 |
4.086e-06 |
68 |
POSITIVE REGULATION OF CELL DEATH |
27 |
605 |
7.381e-08 |
5.051e-06 |
69 |
GLUCOSE HOMEOSTASIS |
14 |
170 |
9.332e-08 |
6.203e-06 |
70 |
CARBOHYDRATE HOMEOSTASIS |
14 |
170 |
9.332e-08 |
6.203e-06 |
71 |
REGULATION OF CELLULAR KETONE METABOLIC PROCESS |
14 |
173 |
1.161e-07 |
7.608e-06 |
72 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
34 |
917 |
1.251e-07 |
8.086e-06 |
73 |
WOUND HEALING |
23 |
470 |
1.423e-07 |
9.07e-06 |
74 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
12 |
126 |
1.609e-07 |
1.012e-05 |
75 |
REGULATION OF HYDROLASE ACTIVITY |
42 |
1327 |
2.887e-07 |
1.789e-05 |
76 |
CELL DEVELOPMENT |
44 |
1426 |
2.923e-07 |
1.789e-05 |
77 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
16 |
250 |
3.682e-07 |
2.225e-05 |
78 |
RESPONSE TO STEROID HORMONE |
23 |
497 |
3.814e-07 |
2.269e-05 |
79 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
21 |
422 |
3.853e-07 |
2.269e-05 |
80 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
38 |
1152 |
4.167e-07 |
2.406e-05 |
81 |
PROTEIN AUTOPHOSPHORYLATION |
14 |
192 |
4.188e-07 |
2.406e-05 |
82 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
14 |
193 |
4.461e-07 |
2.531e-05 |
83 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
33 |
926 |
4.779e-07 |
2.679e-05 |
84 |
GLYCEROLIPID METABOLIC PROCESS |
19 |
356 |
4.91e-07 |
2.72e-05 |
85 |
PEPTIDYL AMINO ACID MODIFICATION |
31 |
841 |
5.351e-07 |
2.929e-05 |
86 |
VASCULATURE DEVELOPMENT |
22 |
469 |
5.498e-07 |
2.975e-05 |
87 |
ENERGY RESERVE METABOLIC PROCESS |
9 |
72 |
5.791e-07 |
3.097e-05 |
88 |
NEGATIVE REGULATION OF CELL CYCLE |
21 |
433 |
5.86e-07 |
3.099e-05 |
89 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
45 |
1518 |
6.405e-07 |
3.348e-05 |
90 |
BLOOD VESSEL MORPHOGENESIS |
19 |
364 |
6.868e-07 |
3.551e-05 |
91 |
EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
8 |
55 |
7.601e-07 |
3.887e-05 |
92 |
PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS |
11 |
120 |
7.815e-07 |
3.952e-05 |
93 |
REGULATION OF CELL CYCLE |
33 |
949 |
8.246e-07 |
4.126e-05 |
94 |
REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY |
10 |
97 |
8.433e-07 |
4.174e-05 |
95 |
RESPONSE TO INSULIN |
14 |
205 |
9.236e-07 |
4.488e-05 |
96 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
37 |
1142 |
9.26e-07 |
4.488e-05 |
97 |
CELL DEATH |
34 |
1001 |
9.41e-07 |
4.514e-05 |
98 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
27 |
691 |
1.011e-06 |
4.802e-05 |
99 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
19 |
375 |
1.073e-06 |
5.041e-05 |
100 |
CELLULAR GLUCAN METABOLIC PROCESS |
8 |
58 |
1.155e-06 |
5.321e-05 |
101 |
GLUCAN METABOLIC PROCESS |
8 |
58 |
1.155e-06 |
5.321e-05 |
102 |
CHEMICAL HOMEOSTASIS |
31 |
874 |
1.208e-06 |
5.511e-05 |
103 |
REGULATION OF MAPK CASCADE |
26 |
660 |
1.395e-06 |
6.302e-05 |
104 |
INSULIN RECEPTOR SIGNALING PATHWAY |
9 |
80 |
1.435e-06 |
6.419e-05 |
105 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
23 |
541 |
1.638e-06 |
7.191e-05 |
106 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
23 |
541 |
1.638e-06 |
7.191e-05 |
107 |
HORMONE MEDIATED SIGNALING PATHWAY |
12 |
158 |
1.849e-06 |
7.967e-05 |
108 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
35 |
1079 |
1.833e-06 |
7.967e-05 |
109 |
REGULATION OF BODY FLUID LEVELS |
22 |
506 |
1.932e-06 |
8.025e-05 |
110 |
HEART DEVELOPMENT |
21 |
466 |
1.899e-06 |
8.025e-05 |
111 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
14 |
218 |
1.918e-06 |
8.025e-05 |
112 |
REGULATION OF CELL ADHESION |
25 |
629 |
1.918e-06 |
8.025e-05 |
113 |
RESPONSE TO ACID CHEMICAL |
17 |
319 |
2.027e-06 |
8.346e-05 |
114 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
19 |
393 |
2.145e-06 |
8.661e-05 |
115 |
DEPHOSPHORYLATION |
16 |
286 |
2.178e-06 |
8.661e-05 |
116 |
REGULATION OF NEURON DEATH |
15 |
252 |
2.123e-06 |
8.661e-05 |
117 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
35 |
1087 |
2.164e-06 |
8.661e-05 |
118 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
23 |
552 |
2.298e-06 |
9.062e-05 |
119 |
CELL PROJECTION ORGANIZATION |
31 |
902 |
2.325e-06 |
9.091e-05 |
120 |
POSITIVE REGULATION OF CELL PROLIFERATION |
29 |
814 |
2.507e-06 |
9.721e-05 |
121 |
RESPONSE TO GROWTH FACTOR |
21 |
475 |
2.565e-06 |
9.863e-05 |
122 |
PEPTIDYL THREONINE MODIFICATION |
7 |
46 |
2.776e-06 |
0.0001059 |
123 |
RESPONSE TO INORGANIC SUBSTANCE |
21 |
479 |
2.924e-06 |
0.0001097 |
124 |
REGULATION OF FATTY ACID METABOLIC PROCESS |
9 |
87 |
2.92e-06 |
0.0001097 |
125 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
30 |
867 |
2.992e-06 |
0.0001114 |
126 |
NEUROGENESIS |
41 |
1402 |
3.048e-06 |
0.0001126 |
127 |
RESPONSE TO EXTERNAL STIMULUS |
49 |
1821 |
3.077e-06 |
0.0001127 |
128 |
RESPONSE TO WOUNDING |
23 |
563 |
3.193e-06 |
0.0001161 |
129 |
RESPONSE TO CARBOHYDRATE |
12 |
168 |
3.514e-06 |
0.0001259 |
130 |
CELLULAR RESPONSE TO STRESS |
44 |
1565 |
3.519e-06 |
0.0001259 |
131 |
CELL ACTIVATION |
23 |
568 |
3.697e-06 |
0.0001313 |
132 |
REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS |
12 |
171 |
4.221e-06 |
0.0001477 |
133 |
REGULATION OF RESPONSE TO NUTRIENT LEVELS |
12 |
171 |
4.221e-06 |
0.0001477 |
134 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
24 |
616 |
4.362e-06 |
0.0001515 |
135 |
TISSUE MORPHOGENESIS |
22 |
533 |
4.467e-06 |
0.0001539 |
136 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
11 |
146 |
5.39e-06 |
0.0001836 |
137 |
MULTICELLULAR ORGANISMAL HOMEOSTASIS |
15 |
272 |
5.405e-06 |
0.0001836 |
138 |
EMBRYO DEVELOPMENT |
30 |
894 |
5.492e-06 |
0.0001852 |
139 |
REGULATION OF PROTEIN LOCALIZATION |
31 |
950 |
6.65e-06 |
0.0002226 |
140 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
17 |
351 |
7.259e-06 |
0.0002413 |
141 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
27 |
771 |
7.762e-06 |
0.0002562 |
142 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
21 |
513 |
8.401e-06 |
0.0002753 |
143 |
CELL CYCLE ARREST |
11 |
154 |
8.987e-06 |
0.0002909 |
144 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
18 |
395 |
9.002e-06 |
0.0002909 |
145 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
15 |
285 |
9.469e-06 |
0.0003018 |
146 |
CELL JUNCTION ORGANIZATION |
12 |
185 |
9.453e-06 |
0.0003018 |
147 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
23 |
602 |
9.543e-06 |
0.0003021 |
148 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
29 |
876 |
1.027e-05 |
0.000323 |
149 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
32 |
1021 |
1.06e-05 |
0.0003312 |
150 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
13 |
220 |
1.104e-05 |
0.0003423 |
151 |
REGULATION OF DEVELOPMENTAL GROWTH |
15 |
289 |
1.118e-05 |
0.0003443 |
152 |
RESPONSE TO ABIOTIC STIMULUS |
32 |
1024 |
1.125e-05 |
0.0003443 |
153 |
CELL MOTILITY |
28 |
835 |
1.166e-05 |
0.0003522 |
154 |
LOCALIZATION OF CELL |
28 |
835 |
1.166e-05 |
0.0003522 |
155 |
REGULATION OF CELLULAR LOCALIZATION |
37 |
1277 |
1.204e-05 |
0.0003616 |
156 |
ERBB SIGNALING PATHWAY |
8 |
79 |
1.228e-05 |
0.0003662 |
157 |
NONMOTILE PRIMARY CILIUM ASSEMBLY |
5 |
23 |
1.257e-05 |
0.0003725 |
158 |
POLYSACCHARIDE METABOLIC PROCESS |
8 |
80 |
1.348e-05 |
0.0003971 |
159 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
23 |
616 |
1.379e-05 |
0.0004034 |
160 |
PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
10 |
134 |
1.571e-05 |
0.0004541 |
161 |
NEGATIVE REGULATION OF STEROID METABOLIC PROCESS |
5 |
24 |
1.57e-05 |
0.0004541 |
162 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
14 |
263 |
1.657e-05 |
0.000473 |
163 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
14 |
263 |
1.657e-05 |
0.000473 |
164 |
REPRODUCTION |
37 |
1297 |
1.694e-05 |
0.0004806 |
165 |
EMBRYONIC MORPHOGENESIS |
21 |
539 |
1.763e-05 |
0.0004973 |
166 |
NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION |
8 |
84 |
1.935e-05 |
0.0005423 |
167 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
10 |
138 |
2.031e-05 |
0.0005659 |
168 |
REGULATION OF GROWTH |
23 |
633 |
2.119e-05 |
0.000587 |
169 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
15 |
307 |
2.273e-05 |
0.0006259 |
170 |
TISSUE HOMEOSTASIS |
11 |
171 |
2.407e-05 |
0.0006588 |
171 |
POSITIVE REGULATION OF CELL COMMUNICATION |
41 |
1532 |
2.535e-05 |
0.0006704 |
172 |
REGULATION OF WNT SIGNALING PATHWAY |
15 |
310 |
2.545e-05 |
0.0006704 |
173 |
TUBE DEVELOPMENT |
21 |
552 |
2.506e-05 |
0.0006704 |
174 |
POSITIVE REGULATION OF GROWTH |
13 |
238 |
2.538e-05 |
0.0006704 |
175 |
TISSUE REMODELING |
8 |
87 |
2.503e-05 |
0.0006704 |
176 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
8 |
87 |
2.503e-05 |
0.0006704 |
177 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
28 |
872 |
2.55e-05 |
0.0006704 |
178 |
HEMOSTASIS |
15 |
311 |
2.642e-05 |
0.0006906 |
179 |
FC RECEPTOR SIGNALING PATHWAY |
12 |
206 |
2.77e-05 |
0.0007202 |
180 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
27 |
829 |
2.803e-05 |
0.0007246 |
181 |
REGULATION OF HEMOPOIESIS |
15 |
314 |
2.952e-05 |
0.0007588 |
182 |
REGULATION OF MULTICELLULAR ORGANISM GROWTH |
7 |
66 |
3.202e-05 |
0.0008141 |
183 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
14 |
279 |
3.186e-05 |
0.0008141 |
184 |
CELLULAR MACROMOLECULE LOCALIZATION |
35 |
1234 |
3.298e-05 |
0.0008339 |
185 |
LIPID MODIFICATION |
12 |
210 |
3.347e-05 |
0.0008418 |
186 |
REGULATION OF FATTY ACID OXIDATION |
5 |
28 |
3.471e-05 |
0.0008684 |
187 |
GLYCEROLIPID BIOSYNTHETIC PROCESS |
12 |
211 |
3.506e-05 |
0.0008724 |
188 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
38 |
1395 |
3.554e-05 |
0.0008797 |
189 |
ORGAN MORPHOGENESIS |
27 |
841 |
3.592e-05 |
0.0008843 |
190 |
HEART MORPHOGENESIS |
12 |
212 |
3.672e-05 |
0.0008993 |
191 |
REGULATION OF CYTOPLASMIC TRANSPORT |
19 |
481 |
3.703e-05 |
0.0009021 |
192 |
GLUCOSE METABOLIC PROCESS |
9 |
119 |
3.768e-05 |
0.0009132 |
193 |
POSITIVE REGULATION OF KINASE ACTIVITY |
19 |
482 |
3.808e-05 |
0.0009181 |
194 |
ORGAN GROWTH |
7 |
68 |
3.894e-05 |
0.000934 |
195 |
REGULATION OF AUTOPHAGY |
13 |
249 |
4.059e-05 |
0.0009685 |
196 |
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
15 |
323 |
4.083e-05 |
0.0009692 |
197 |
RESPONSE TO ALCOHOL |
16 |
362 |
4.111e-05 |
0.0009709 |
198 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
26 |
801 |
4.199e-05 |
0.0009868 |
199 |
IMMUNE EFFECTOR PROCESS |
19 |
486 |
4.257e-05 |
0.0009953 |
200 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
17 |
404 |
4.384e-05 |
0.00102 |
201 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
11 |
183 |
4.493e-05 |
0.00104 |
202 |
ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS |
12 |
217 |
4.608e-05 |
0.001061 |
203 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
6 |
48 |
4.644e-05 |
0.001064 |
204 |
CIRCULATORY SYSTEM PROCESS |
16 |
366 |
4.686e-05 |
0.001065 |
205 |
REGULATION OF INTRACELLULAR TRANSPORT |
22 |
621 |
4.69e-05 |
0.001065 |
206 |
PROTEIN CATABOLIC PROCESS |
21 |
579 |
5.005e-05 |
0.00113 |
207 |
ORGANOPHOSPHATE BIOSYNTHETIC PROCESS |
18 |
450 |
5.055e-05 |
0.001136 |
208 |
MULTICELLULAR ORGANISM REPRODUCTION |
25 |
768 |
5.663e-05 |
0.001267 |
209 |
REGULATION OF PLATELET ACTIVATION |
5 |
31 |
5.804e-05 |
0.001292 |
210 |
LEUKOCYTE ACTIVATION |
17 |
414 |
5.933e-05 |
0.001308 |
211 |
REGULATION OF WOUND HEALING |
9 |
126 |
5.905e-05 |
0.001308 |
212 |
CELL PART MORPHOGENESIS |
22 |
633 |
6.218e-05 |
0.001365 |
213 |
GLYCEROPHOSPHOLIPID METABOLIC PROCESS |
14 |
297 |
6.275e-05 |
0.001371 |
214 |
NEGATIVE REGULATION OF TRANSPORT |
18 |
458 |
6.337e-05 |
0.001378 |
215 |
RHYTHMIC PROCESS |
14 |
298 |
6.505e-05 |
0.001408 |
216 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
11 |
191 |
6.623e-05 |
0.001427 |
217 |
REGULATION OF LIPID BIOSYNTHETIC PROCESS |
9 |
128 |
6.676e-05 |
0.001432 |
218 |
NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY |
5 |
32 |
6.803e-05 |
0.001452 |
219 |
NEURON DIFFERENTIATION |
27 |
874 |
6.9e-05 |
0.001466 |
220 |
POSITIVE REGULATION OF LOCOMOTION |
17 |
420 |
7.078e-05 |
0.001497 |
221 |
REGULATION OF CELL CELL ADHESION |
16 |
380 |
7.298e-05 |
0.001537 |
222 |
LYMPHOCYTE ACTIVATION |
15 |
342 |
7.787e-05 |
0.001632 |
223 |
SEX DIFFERENTIATION |
13 |
266 |
7.966e-05 |
0.001662 |
224 |
REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
6 |
53 |
8.206e-05 |
0.001705 |
225 |
REGULATION OF MITOTIC CELL CYCLE |
18 |
468 |
8.338e-05 |
0.001724 |
226 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
8 |
103 |
8.443e-05 |
0.001738 |
227 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
11 |
197 |
8.741e-05 |
0.001784 |
228 |
POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY |
11 |
197 |
8.741e-05 |
0.001784 |
229 |
DEFENSE RESPONSE TO VIRUS |
10 |
164 |
8.837e-05 |
0.001796 |
230 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
8 |
104 |
9.04e-05 |
0.001829 |
231 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
18 |
472 |
9.283e-05 |
0.00187 |
232 |
CEREBRAL CORTEX DEVELOPMENT |
8 |
105 |
9.672e-05 |
0.001935 |
233 |
RESPONSE TO DRUG |
17 |
431 |
9.692e-05 |
0.001935 |
234 |
EPITHELIUM DEVELOPMENT |
28 |
945 |
0.0001029 |
0.002013 |
235 |
REGULATION OF FAT CELL DIFFERENTIATION |
8 |
106 |
0.0001034 |
0.002013 |
236 |
POSITIVE REGULATION OF CELL ACTIVATION |
14 |
311 |
0.0001024 |
0.002013 |
237 |
REGULATION OF GLUCOSE METABOLIC PROCESS |
8 |
106 |
0.0001034 |
0.002013 |
238 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
6 |
55 |
0.0001013 |
0.002013 |
239 |
FAT CELL DIFFERENTIATION |
8 |
106 |
0.0001034 |
0.002013 |
240 |
WNT SIGNALING PATHWAY |
15 |
351 |
0.0001039 |
0.002015 |
241 |
REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS |
5 |
35 |
0.0001061 |
0.002048 |
242 |
RESPONSE TO OXIDATIVE STRESS |
15 |
352 |
0.0001073 |
0.002062 |
243 |
INTRACELLULAR RECEPTOR SIGNALING PATHWAY |
10 |
168 |
0.000108 |
0.002067 |
244 |
NEGATIVE REGULATION OF LIPID METABOLIC PROCESS |
7 |
80 |
0.000111 |
0.002118 |
245 |
DRUG TRANSMEMBRANE TRANSPORT |
4 |
19 |
0.000112 |
0.002118 |
246 |
REGULATION OF MICROTUBULE BASED MOVEMENT |
4 |
19 |
0.000112 |
0.002118 |
247 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
17 |
437 |
0.0001145 |
0.002157 |
248 |
CELL CYCLE |
35 |
1316 |
0.0001193 |
0.002238 |
249 |
POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS |
5 |
36 |
0.0001218 |
0.002276 |
250 |
REGULATION OF CHROMOSOME ORGANIZATION |
13 |
278 |
0.0001239 |
0.002298 |
251 |
REGULATION OF PROTEOLYSIS |
23 |
711 |
0.0001239 |
0.002298 |
252 |
NEGATIVE REGULATION OF NEURON DEATH |
10 |
171 |
0.000125 |
0.002307 |
253 |
RESPONSE TO HYDROGEN PEROXIDE |
8 |
109 |
0.0001258 |
0.002313 |
254 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
20 |
573 |
0.0001271 |
0.002329 |
255 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
10 |
172 |
0.0001311 |
0.002392 |
256 |
MORPHOGENESIS OF AN EPITHELIUM |
16 |
400 |
0.0001322 |
0.002403 |
257 |
HOMEOSTASIS OF NUMBER OF CELLS |
10 |
175 |
0.0001511 |
0.002735 |
258 |
CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS |
12 |
246 |
0.0001521 |
0.002742 |
259 |
IMMUNE SYSTEM DEVELOPMENT |
20 |
582 |
0.0001564 |
0.002805 |
260 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
16 |
406 |
0.0001567 |
0.002805 |
261 |
ANATOMICAL STRUCTURE HOMEOSTASIS |
13 |
285 |
0.0001585 |
0.002826 |
262 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
23 |
724 |
0.0001615 |
0.002867 |
263 |
POSITIVE REGULATION OF CHROMATIN MODIFICATION |
7 |
85 |
0.0001628 |
0.002872 |
264 |
REGULATION OF ORGANELLE ORGANIZATION |
32 |
1178 |
0.000163 |
0.002872 |
265 |
REGULATION OF GLUCOSE IMPORT |
6 |
60 |
0.0001652 |
0.002891 |
266 |
CELLULAR CARBOHYDRATE METABOLIC PROCESS |
9 |
144 |
0.0001648 |
0.002891 |
267 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
25 |
823 |
0.0001675 |
0.00292 |
268 |
NOTCH SIGNALING PATHWAY |
8 |
114 |
0.0001718 |
0.002983 |
269 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
7 |
86 |
0.0001752 |
0.00302 |
270 |
GROWTH |
16 |
410 |
0.0001752 |
0.00302 |
271 |
MACROMOLECULE CATABOLIC PROCESS |
27 |
926 |
0.0001782 |
0.00306 |
272 |
PEPTIDYL TYROSINE AUTOPHOSPHORYLATION |
5 |
39 |
0.0001799 |
0.003078 |
273 |
CELLULAR RESPONSE TO HYDROGEN PEROXIDE |
6 |
61 |
0.0001812 |
0.003088 |
274 |
CELL CYCLE PROCESS |
30 |
1081 |
0.000183 |
0.003108 |
275 |
SKELETAL SYSTEM DEVELOPMENT |
17 |
455 |
0.000185 |
0.003131 |
276 |
NEURON PROJECTION DEVELOPMENT |
19 |
545 |
0.0001903 |
0.003208 |
277 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
9 |
147 |
0.0001925 |
0.003234 |
278 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
15 |
372 |
0.0001961 |
0.003282 |
279 |
NEURON DEVELOPMENT |
22 |
687 |
0.0002007 |
0.003347 |
280 |
REGULATION OF COAGULATION |
7 |
88 |
0.0002023 |
0.003362 |
281 |
NEGATIVE REGULATION OF MUSCLE CONTRACTION |
4 |
22 |
0.0002046 |
0.003389 |
282 |
DEVELOPMENTAL GROWTH |
14 |
333 |
0.0002085 |
0.003441 |
283 |
RESPONSE TO ESTROGEN |
11 |
218 |
0.0002131 |
0.003503 |
284 |
POSITIVE REGULATION OF CELL ADHESION |
15 |
376 |
0.00022 |
0.003604 |
285 |
REGULATION OF TRANSPORT |
43 |
1804 |
0.0002229 |
0.003639 |
286 |
POSITIVE REGULATION OF CHROMOSOME ORGANIZATION |
9 |
150 |
0.000224 |
0.003645 |
287 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
10 |
184 |
0.0002271 |
0.003682 |
288 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
9 |
152 |
0.0002473 |
0.003975 |
289 |
REGULATION OF CHROMATIN ORGANIZATION |
9 |
152 |
0.0002473 |
0.003975 |
290 |
PEPTIDYL TYROSINE MODIFICATION |
10 |
186 |
0.0002478 |
0.003975 |
291 |
UROGENITAL SYSTEM DEVELOPMENT |
13 |
299 |
0.0002531 |
0.004047 |
292 |
REGULATION OF CELL PROJECTION ORGANIZATION |
19 |
558 |
0.0002561 |
0.004076 |
293 |
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
6 |
65 |
0.0002576 |
0.004076 |
294 |
GENITALIA DEVELOPMENT |
5 |
42 |
0.0002571 |
0.004076 |
295 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
20 |
609 |
0.000283 |
0.004463 |
296 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
26 |
905 |
0.0002958 |
0.00465 |
297 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
9 |
156 |
0.0002999 |
0.004699 |
298 |
POSITIVE REGULATION OF NEURON DEATH |
6 |
67 |
0.0003042 |
0.00475 |
299 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
33 |
1275 |
0.0003095 |
0.004812 |
300 |
HEAD DEVELOPMENT |
22 |
709 |
0.0003103 |
0.004812 |
301 |
REGULATION OF IMMUNE RESPONSE |
25 |
858 |
0.0003143 |
0.004845 |
302 |
HEXOSE METABOLIC PROCESS |
9 |
157 |
0.0003144 |
0.004845 |
303 |
REGULATION OF NEURON APOPTOTIC PROCESS |
10 |
192 |
0.0003194 |
0.004906 |
304 |
NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS |
5 |
44 |
0.000321 |
0.004913 |
305 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
8 |
125 |
0.0003229 |
0.004926 |
306 |
RESPONSE TO TYPE I INTERFERON |
6 |
68 |
0.0003299 |
0.005016 |
307 |
CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS |
4 |
25 |
0.0003427 |
0.005111 |
308 |
GLYCOGEN BIOSYNTHETIC PROCESS |
4 |
25 |
0.0003427 |
0.005111 |
309 |
EPITHELIAL CELL APOPTOTIC PROCESS |
4 |
25 |
0.0003427 |
0.005111 |
310 |
DRUG TRANSPORT |
4 |
25 |
0.0003427 |
0.005111 |
311 |
GLUCAN BIOSYNTHETIC PROCESS |
4 |
25 |
0.0003427 |
0.005111 |
312 |
PEPTIDE CATABOLIC PROCESS |
4 |
25 |
0.0003427 |
0.005111 |
313 |
REGULATION OF JNK CASCADE |
9 |
159 |
0.0003452 |
0.005132 |
314 |
CONNECTIVE TISSUE DEVELOPMENT |
10 |
194 |
0.0003469 |
0.00514 |
315 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
11 |
232 |
0.0003632 |
0.005365 |
316 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
14 |
352 |
0.000366 |
0.00539 |
317 |
NEGATIVE REGULATION OF HEMOPOIESIS |
8 |
128 |
0.000379 |
0.005563 |
318 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
10 |
197 |
0.0003917 |
0.005731 |
319 |
CELL JUNCTION ASSEMBLY |
8 |
129 |
0.0003993 |
0.005825 |
320 |
PHOSPHOLIPID BIOSYNTHETIC PROCESS |
11 |
235 |
0.0004049 |
0.005887 |
321 |
INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY |
6 |
71 |
0.0004172 |
0.006028 |
322 |
ADHERENS JUNCTION ORGANIZATION |
6 |
71 |
0.0004172 |
0.006028 |
323 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
11 |
236 |
0.0004196 |
0.006045 |
324 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
10 |
199 |
0.0004242 |
0.006092 |
325 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
7 |
100 |
0.0004441 |
0.006358 |
326 |
PROTEIN LOCALIZATION TO CILIUM |
4 |
27 |
0.0004653 |
0.006629 |
327 |
B CELL ACTIVATION |
8 |
132 |
0.0004658 |
0.006629 |
328 |
REGULATION OF EPITHELIAL CELL MIGRATION |
9 |
166 |
0.0004731 |
0.006712 |
329 |
NEGATIVE REGULATION OF COAGULATION |
5 |
48 |
0.0004842 |
0.006835 |
330 |
REGULATION OF ORGAN GROWTH |
6 |
73 |
0.0004847 |
0.006835 |
331 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
8 |
133 |
0.0004899 |
0.006887 |
332 |
ORGANOPHOSPHATE METABOLIC PROCESS |
25 |
885 |
0.0004958 |
0.006949 |
333 |
REGULATION OF T CELL TOLERANCE INDUCTION |
3 |
12 |
0.0005051 |
0.007037 |
334 |
RESPONSE TO BIOTIC STIMULUS |
25 |
886 |
0.000504 |
0.007037 |
335 |
PHOSPHOLIPID METABOLIC PROCESS |
14 |
364 |
0.0005108 |
0.007095 |
336 |
REGULATION OF PROTEIN BINDING |
9 |
168 |
0.0005161 |
0.007147 |
337 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
6 |
74 |
0.0005215 |
0.007158 |
338 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
15 |
408 |
0.0005202 |
0.007158 |
339 |
REGULATION OF STEROID METABOLIC PROCESS |
6 |
74 |
0.0005215 |
0.007158 |
340 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
12 |
282 |
0.0005268 |
0.007171 |
341 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
7 |
103 |
0.000531 |
0.007171 |
342 |
REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY |
5 |
49 |
0.0005332 |
0.007171 |
343 |
REGULATION OF STEROID BIOSYNTHETIC PROCESS |
5 |
49 |
0.0005332 |
0.007171 |
344 |
TUBE MORPHOGENESIS |
13 |
323 |
0.0005279 |
0.007171 |
345 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
7 |
103 |
0.000531 |
0.007171 |
346 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
14 |
365 |
0.0005248 |
0.007171 |
347 |
CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER |
4 |
28 |
0.0005371 |
0.007202 |
348 |
REGULATION OF LEUKOCYTE PROLIFERATION |
10 |
206 |
0.000556 |
0.007434 |
349 |
CELLULAR GLUCOSE HOMEOSTASIS |
6 |
75 |
0.0005605 |
0.007473 |
350 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
14 |
368 |
0.0005689 |
0.007562 |
351 |
LIPID METABOLIC PROCESS |
30 |
1158 |
0.000579 |
0.007675 |
352 |
CELLULAR RESPONSE TO RADIATION |
8 |
137 |
0.0005964 |
0.007884 |
353 |
RESPONSE TO VIRUS |
11 |
247 |
0.000614 |
0.008094 |
354 |
MUSCLE ADAPTATION |
4 |
29 |
0.0006164 |
0.008102 |
355 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
10 |
209 |
0.0006221 |
0.008154 |
356 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
18 |
554 |
0.0006431 |
0.008381 |
357 |
CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS |
5 |
51 |
0.0006425 |
0.008381 |
358 |
POSITIVE REGULATION OF GLUCONEOGENESIS |
3 |
13 |
0.0006501 |
0.008449 |
359 |
POSITIVE REGULATION OF CELL CYCLE |
13 |
332 |
0.0006818 |
0.008836 |
360 |
GLIOGENESIS |
9 |
175 |
0.0006924 |
0.008949 |
361 |
RESPONSE TO EPIDERMAL GROWTH FACTOR |
4 |
30 |
0.0007037 |
0.00902 |
362 |
RESPONSE TO METAL ION |
13 |
333 |
0.000701 |
0.00902 |
363 |
REGULATION OF LIPID CATABOLIC PROCESS |
5 |
52 |
0.000703 |
0.00902 |
364 |
GENERATION OF PRECURSOR METABOLITES AND ENERGY |
12 |
292 |
0.0007159 |
0.009151 |
365 |
DENDRITE DEVELOPMENT |
6 |
79 |
0.0007394 |
0.009401 |
366 |
ANGIOGENESIS |
12 |
293 |
0.0007376 |
0.009401 |
367 |
PLATELET ACTIVATION |
8 |
142 |
0.0007552 |
0.009548 |
368 |
FC EPSILON RECEPTOR SIGNALING PATHWAY |
8 |
142 |
0.0007552 |
0.009548 |
369 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
5 |
53 |
0.0007677 |
0.00968 |
370 |
REGULATION OF DEFENSE RESPONSE |
22 |
759 |
0.0007719 |
0.009707 |
371 |
CELLULAR LIPID METABOLIC PROCESS |
25 |
913 |
0.0007756 |
0.009728 |
372 |
REGULATION OF BLOOD CIRCULATION |
12 |
295 |
0.0007826 |
0.009763 |
373 |
REGULATION OF OSSIFICATION |
9 |
178 |
0.0007817 |
0.009763 |
374 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
14 |
381 |
0.0007976 |
0.009924 |